News & Media

Press releases & statements

Nov 28, 2023

COVID-19

Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization

Read full article

Oct 31, 2023

COVID-19

Novavax's Updated COVID-19 Vaccine Now Approved in the EU

Read full article

Oct 31, 2023

COVID-19

Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU

Read full article

Oct 18, 2023

COVID-19

Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom

Read full article

Oct 18, 2023

COVID-19

Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore

Read full article

Oct 16, 2023

Statement

COVID-19

Novavax Statement on 2023-2024 COVID-19 Vaccination Season

Read full article

Oct 13, 2023

COVID-19

Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S.

Read full article

Oct 11, 2023

COVID-19,Seasonal influenza

Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023

Read full article

Oct 10, 2023

COVID-19

Novavax Launches Choose to Protect™ Campaign to Educate Public About Importance of Updated COVID Vaccination this Fall

Read full article

Oct 3, 2023

COVID-19

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Read full article

Showper page